Imatinib treatment and longitudinal growth in pediatric patients with chronic myeloid leukemia: influence of demographic, pharmacological, and genetic factors in the German CML-PAED cohort (2024) Stiehler S, Sembill S, Schleicher O, Marx M, Rauh M, Krumbholz M, Karow A, et al. Journal article Randomized phase III GnG study on two schedules of gemtuzumab ozogamicin as adjunct to intensive induction therapy and double-blinded intensive postremission therapy with or without glasdegib in patients with newly diagnosed acute myeloid leukemia (2024) Jaramillo S, Krisam J, Le Cornet L, Kratzmann M, Baumann L, Eissymont O, Crysandt M, et al. Journal article Massive parallel sequencing unveils homologous recombination deficiency in follicular dendritic cell sarcoma (2024) Lorenzi L, Haferlach T, Mori L, Simbeni M, Walter W, Balzarini P, Meggendorfer M, et al. Journal article Time from diagnosis to treatment has no impact on survival in newly diagnosed acute myeloid leukemia treated with venetoclax-based regimens. (2024) Baden D, Zukunft S, Hernandez G, Wolgast N, Steinhauser S, Pohlmann A, Schliemann C, et al. Journal article HLA-C*04:09N is expressed at the cell surface and triggers peptide-specific T-cell activation. (2024) Welters C, Welters ML, Stadler S, Bullinger L, Strobel J, Hackstein H, Dhamodaran A, et al. Journal article Somatic variant profiling in chronic phase pediatric chronic myeloid leukemia. (2024) Behrens YL, Gaschler L, Nienhold R, Reinkens T, Schirmer E, Knöβ S, Strasser R, et al. Journal article Blockade of the CD47/SIRPα checkpoint axis potentiates the macrophage-mediated antitumor efficacy of tafasitamab. (2024) Biedermann A, Patra-Kneuer M, Mougiakakos D, Büttner-Herold M, Mangelberger-Eberl D, Berges J, Kellner C, et al. Journal article Approaches for bridging therapy prior to chimeric antigen receptor T cells for relapsed/refractory acute lymphoblastic B-lineage leukemia in children and young adults. (2024) Feuchtinger T, Bader P, Subklewe M, Breidenbach M, Willier S, Metzler M, Gökbuget N, et al. Journal article, Review article Midostaurin in addition to intensive chemotherapy in acute myeloid leukemia with t(8;21) and KIT and/or FLT3- ITD mutations: results of the SAL MIDOKIT trial (2023) Ruhnke L, Röllig C, Herold S, Sauer T, Brandts CH, Steffen B, Schäfer-Eckart K, et al. Journal article Impact of trisomy 19 on outcome according to genetic makeup in patients with acute myeloid leukemia (2023) Kayser S, Martínez-Cuadrón D, Rodriguez-Veiga R, Hänel M, Tormo M, Schäfer-Eckart K, Botella C, et al. Journal article